Clinical Trial

Prognostic Value of the LVOT VTI in STEMI Patients Undergoing PPCI

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
* To determine whether LVOT VTI \< 15 cm predicts the development of in-hospital cardiogenic shock or need for vasopressors in STEMI patients undergoing primary PCI. * To assess association of LVOT VTI with other adverse outcomes (in-hospital death, heart failure, arrhythmias, need for mechanical ventilation, prolonged hospital stay).
Trial Details
NCT Number NCT07114978
Lead Sponsor Assiut University
Conditions LVOT VTI, STEMI - ST Elevation Myocardial Infarction (MI), Primary Percutaneous Coronary Intervention
Enrollment 125 participants
Start Date 2025-08-01
Primary Completion 2026-08 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-08-11